Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study shows safety, pharmacokinetics and preliminary anti-tumor activity of RP12146 in patients with solid tumors, including extensive-stage small-cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• RP12146

Snippet

Sponsor: Rhizen Pharmaceuticals SA | Conditions: Solid Tumor, Extensive-stage Small-cell Lung Cancer | Phase 1 | Status: COMPLETED